Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 65 entries
View as:

Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections

Phase: N/A Priority: Normal
NCT ID: NCT00711802 Org: User:
Start: 07/23/08 End: 10/11/13 Due: 10/11/14

Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT00921024 Org: User:
Start: 06/30/09 End: 03/11/10 Due: 03/11/11

Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)

Phase: N/A Priority: Normal
NCT ID: NCT02276482 Org: User:
Start: 03/25/15 End: 09/17/18 Due: 09/17/19

Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae

Phase: N/A Priority: Normal
NCT ID: NCT00540072 Org: User:
Start: 07/30/01 End: 02/27/02 Due: 02/27/03

Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics

Phase: N/A Priority: Normal
NCT ID: NCT01019395 Org: User:
Start: 01/05/10 End: 03/20/12 Due: 03/20/13

Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia

Phase: N/A Priority: Normal
NCT ID: NCT00695903 Org: User:
Start: 09/17/08 End: 10/01/10 Due: 10/01/11

Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00626275 Org: User:
Start: 10/31/07 End: 09/30/08 Due: 09/30/09

Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02508740 Org: User:
Start: 09/30/13 End: 12/31/13 Due: 12/31/14

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus

Phase: N/A Priority: Normal
NCT ID: NCT00205842 Org: User:
Start: 06/30/04 End: 12/31/05 Due: 12/31/06

Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001)

Phase: N/A Priority: Normal
NCT ID: NCT02341599 Org: User:
Start: 12/11/14 End: 04/20/15 Due: 04/20/16

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections

Phase: N/A Priority: Normal
NCT ID: NCT01445678 Org: User:
Start: 12/23/11 End: 10/15/13 Due: 10/15/14

Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas

Phase: N/A Priority: Normal
NCT ID: NCT00295178 Org: User:
Start: 02/20/06 End: 08/09/06 Due: 08/09/07

Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)

Phase: N/A Priority: Normal
NCT ID: NCT00490737 Org: User:
Start: 08/12/07 End: 05/12/08 Due: 05/12/09

Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA

Phase: N/A Priority: Normal
NCT ID: NCT01419184 Org: User:
Start: 09/09/11 End: 10/05/12 Due: 10/05/13

Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)

Phase: N/A Priority: Normal
NCT ID: NCT02266706 Org: User:
Start: 09/17/14 End: 06/15/17 Due: 06/15/18

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Phase: N/A Priority: Normal
NCT ID: NCT00428844 Org: User:
Start: 06/26/07 End: 06/23/10 Due: 06/23/11

Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7625A-007)

Phase: N/A Priority: Normal
NCT ID: NCT02387372 Org: User:
Start: 02/05/15 End: 06/16/17 Due: 06/16/18

Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics

Phase: N/A Priority: Normal
NCT ID: NCT00136292 Org: User:
Start: 08/24/05 End: 08/09/06 Due: 08/09/07

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01696643 Org: User:
Start: 10/12/12 End: 07/21/14 Due: 07/21/15

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)

Phase: N/A Priority: Normal
NCT ID: NCT00638157 Org: User:
Start: 02/13/09 End: 11/09/11 Due: 11/09/12

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus

Phase: N/A Priority: Normal
NCT ID: NCT00388258 Org: User:
Start: 03/01/01 End: 12/01/02 Due: 12/01/03

Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00135577 Org: User:
Start: 09/30/04 End: 04/30/07 Due: 04/30/08

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01901302 Org: User:
Start: 05/20/13 End: 02/13/14 Due: 02/13/15

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

Phase: N/A Priority: Normal
NCT ID: NCT00228592 Org: User:
Start: - End: 08/31/05 Due: 08/31/06

Clinical Outcomes After Bowel Resection in Patients Receiving Alvimopan Versus Patients Not Receiving Alvimopan in the Premier Perspective Database

Phase: N/A Priority: Normal
NCT ID: NCT01150760 Org: User:
Start: 04/30/10 End: 08/31/10 Due: 08/31/11